Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 27, 2017 08:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Appoints Renowned Biotech Entrepreneur Dr. Thomas F. Widmann to its Board of Directors

RUTHERFORD, N.J., Nov. 27, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
November 09, 2017 07:22 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Reports Record Third Quarter 2017 Revenue and 134% Increase in Contracted Bookings from Major Biotech and Pharmaceutical Companies

Actively Working with 9 of Top 10 Biopharma Companies Globally Revenue Increased 19% to $8.0 Million, Gross Margin Improved to 43% Conference call at 8:30 a.m. EST, Thursday, November 9, 2017 ...
November 08, 2017 07:30 ET | Source: Cancer Genetics, Inc.

Cancer Genetics to Present Insights to Advance Precision Medicine in Non-Small Cell Lung Cancer (NSCLC) at AMP Annual Meeting 2017

The two presentations at AMP highlight the role of next-generation sequencing in lung cancer biomarker testing, including CGI’s liquid biopsy test, Liquid::Lung-cfDNA™Thermo Fisher’s next-generation...
November 02, 2017 07:30 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. is Among the First To Drive New FDA-Approved Testing Paradigm for Non-Small Cell Lung Cancer Patients by Offering Thermo Fisher Scientific’s Oncomine Dx Target Test

Thermo Fisher’s multi-biomarker test helps match lung cancer patients to FDA-approved therapies in days instead of weeksCGI and Thermo Fisher are collaborating with pharmaceutical partners and...
November 01, 2017 10:42 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Announces Timing for Third Quarter 2017 Earnings Call & Update on vivoPharm Integration on Thursday, November 9th

RUTHERFORD, N.J., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) a leader in enabling precision medicine for oncology through molecular markers and diagnostics, announced...
October 31, 2017 07:45 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Named One of the Top 10 Drug Discovery & Development Solution Providers by Panel of Industry Experts at Pharma Tech Outlook

RUTHERFORD, N.J., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) (“CGI” or “The Company”), a leader in enabling precision medicine for oncology through molecular markers and...
October 30, 2017 08:03 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. – a Leader in Personalized Medicine – Launches AntigenID™, Solidifying CGI’s Position as a Precision Oncology Leader in the Fast Growing, Rapidly-Evolving Field of Immuno-Oncology Therapy & Drug Development

CGI’s AntigenID™ identifies neoantigens and neoantigen signatures that accelerate immuno-oncology drug identification, predict patient-specific immune therapy response, and help create personalized...
October 12, 2017 07:30 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. to Host Panel Discussion on “The Convergence of Artificial Intelligence and Healthcare - New Developments in Precision Medicine” During the 3rd Annual Dawson James Small Cap Growth Conference on October 18th

Cancer Genetics Will Also Present a Corporate Overview on Thursday, October 19th RUTHERFORD, N.J., Oct. 12, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) (“CGI” or “The Company”), a...
September 29, 2017 07:30 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. to Present at The MicroCap Conference on October 5th in New York City at the Essex House

RUTHERFORD, N.J., Sept. 29, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) (the Company and CGI), a leader in enabling precision medicine for oncology through molecular markers and...
September 22, 2017 08:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. to Present at the 2017 Disruptive Growth Company Showcase NYC on September 27th

RUTHERFORD, N.J., Sept. 22, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) (the Company and CGI), a leader in enabling precision medicine for oncology through molecular markers and...